Ryan Specialty Holdings Inc. (NYSE:RYAN) Shares Purchased by Peregrine Capital Management LLC

Peregrine Capital Management LLC raised its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 3.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 226,193 shares of the company's stock after buying an additional 7,170 shares during the quarter. Peregrine Capital Management LLC owned about 0.09% of Ryan Specialty worth $16,709,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Raymond James Financial Inc. purchased a new stake in Ryan Specialty during the fourth quarter valued at approximately $94,484,000. Norges Bank purchased a new position in Ryan Specialty in the fourth quarter worth $78,358,000. Millennium Management LLC increased its position in shares of Ryan Specialty by 1,111.4% during the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock worth $75,329,000 after purchasing an additional 1,077,169 shares in the last quarter. CIBC Private Wealth Group LLC lifted its holdings in shares of Ryan Specialty by 6,911.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock valued at $48,036,000 after purchasing an additional 774,718 shares during the last quarter. Finally, Artemis Investment Management LLP purchased a new stake in shares of Ryan Specialty during the 1st quarter valued at $57,023,000. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Price Performance

RYAN stock traded down $1.78 during mid-day trading on Wednesday, reaching $65.84. 1,469,406 shares of the company's stock were exchanged, compared to its average volume of 915,348. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.05 and a quick ratio of 1.05. Ryan Specialty Holdings Inc. has a 12-month low of $55.67 and a 12-month high of $77.16. The stock's 50 day moving average is $68.12 and its 200 day moving average is $68.05. The company has a market cap of $17.28 billion, a price-to-earnings ratio of 193.65, a price-to-earnings-growth ratio of 1.80 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business's revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.35 EPS. On average, research analysts expect that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were given a $0.12 dividend. The ex-dividend date was Tuesday, May 13th. This represents a $0.48 annualized dividend and a dividend yield of 0.73%. Ryan Specialty's dividend payout ratio (DPR) is 141.18%.

Analyst Upgrades and Downgrades

RYAN has been the subject of several research reports. The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $74.00 to $81.00 in a research note on Tuesday, May 13th. TD Cowen assumed coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Morgan Stanley boosted their price target on Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Finally, Wells Fargo & Company dropped their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $75.58.

Insider Transactions at Ryan Specialty

In related news, Director David P. Bolger sold 5,000 shares of the firm's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the transaction, the director directly owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the sale, the executive vice president owned 1,117 shares of the company's stock, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. 52.21% of the stock is owned by insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.